Telesis Bio Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS

Ticker Exchange SIC # Website Latest Ticker
TBIO Nasdaq 3826 https://codexdna.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Telesis Bio Inc

Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates - Mar 21st, 2023 9:25 pm
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance - Mar 21st, 2023 8:05 pm
Telesis Bio to Present at Festival of Biologics Conference - Mar 16th, 2023 10:00 am
Telesis Bio to Present at RNA Leaders Europe Congress - Mar 14th, 2023 10:00 am
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023 - Mar 9th, 2023 9:30 pm
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference - Feb 27th, 2023 2:00 pm
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation - Feb 16th, 2023 2:00 pm
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results - Jan 9th, 2023 2:00 pm